Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Spironolactone plus finasteride reduces hirsutism more effectively.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Hyperaesthetic leucotrichia in horses causes painful, recurring skin lesions and hair color changes, especially in Arabian and American paint horses.

Vitiligo and lupus can occur together, requiring careful treatment to manage both conditions.

Leukemia can sometimes appear as unusual skin issues in children.

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Tangent screens help detect visual field defects from vigabatrin.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Extracellular vesicles can help regenerate bones but need more research for safe clinical use.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

The medication lopinavir-ritonavir may cause severe hair loss.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Latanoprost effectively and safely promotes eyelash growth.

Telogen effluvium is a condition that causes temporary hair loss.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

High serum fluoride levels may be linked to hair loss.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.